Clinical trials
Completed Glycogen Storage Disease Type II trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
12 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2011 | 2 |
| 2013 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Genzyme, a Sanofi Company | 4 |
| Amicus Therapeutics | 3 |
| LMU Klinikum | 2 |
| BioMarin Pharmaceutical | 1 |
| Spark Therapeutics, Inc. | 1 |
| University of Erlangen-Nürnberg Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Glycogen Storage Disease Type II | 12 |
| Anaphylaxis | 1 |
| Lysosomal Storage Diseases | 1 |
| Myositis, Inclusion Body | 1 |
| Myotonic Dystrophy | 1 |
| Nociceptive Pain | 1 |
| Spinal Muscular Atrophies of Childhood | 1 |
Trials
Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.